PerspectiveDRUG DESIGN

Clinical chemoproteomics—Opportunities and obstacles

See allHide authors and affiliations

Science Translational Medicine  19 Apr 2017:
Vol. 9, Issue 386, eaaf7951
DOI: 10.1126/scitranslmed.aaf7951

Article Information

vol. 9 no. 386

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication March 31, 2016
  • Accepted for publication March 6, 2017

Author Information

  1. Lyn H. Jones1,* and
  2. Hendrik Neubert2
  1. 1Medicine Design, Pfizer, 610 Main Street, Cambridge, MA 02139, USA.
  2. 2Biomedicine Design, Pfizer, Andover, MA 01810, USA.
  1. *Corresponding author. Email: lynhowardjones{at}gmail.com

Altmetric

Article usage

Article usage: April 2017 to April 2018

AbstractFullPdf
Apr 20173443134273
May 20172832543
Jun 20171011836
Jul 2017138929
Aug 20171361817
Sep 20171701841
Oct 201758716
Nov 201762713
Dec 20174557
Jan 2018781019
Feb 201849816
Mar 201855918
Apr 2018731011